Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
5.13
-0.05 (-0.97%)
At close: Dec 5, 2025, 4:00 PM EST
5.15
+0.02 (0.39%)
After-hours: Dec 5, 2025, 7:57 PM EST
Sana Biotechnology Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Sana Biotechnology stock have an average target of 7.83, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 52.63% from the current stock price of 5.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +16.96% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +75.44% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +55.95% | Oct 30, 2025 |
| Wedbush | Wedbush | Buy Initiates $5 | Buy | Initiates | $5 | -2.53% | Sep 24, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $12 | Buy | Initiates | $12 | +133.92% | Jul 3, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.90
from -1.16
EPS Next Year
-0.57
from -0.90
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.87 | -0.40 | ||||
| Avg | -0.90 | -0.57 | ||||
| Low | -0.90 | -0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.